<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Maxime-Brotz on Jeantet</title><link>https://www.jeantet.fr/en/news/authors/maxime-brotz/</link><description>Recent content in Maxime-Brotz on Jeantet</description><generator>Hugo</generator><language>en</language><lastBuildDate>Tue, 17 Nov 2026 12:12:56 +0100</lastBuildDate><atom:link href="https://www.jeantet.fr/en/news/authors/maxime-brotz/index.xml" rel="self" type="application/rss+xml"/><item><title>Jeantet advises FrenchFood Capital, Unexo and all shareholders on the sale of the Bharal Group to Naxicap Partners</title><link>https://www.jeantet.fr/en/news/2026-10-20-jeantet-advises-frenchfood-capital-unexo-and-all-shareholders-on-the-sale-of-the-bharal-group-to-naxicap-partners/</link><pubDate>Tue, 20 Oct 2026 19:42:30 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2026-10-20-jeantet-advises-frenchfood-capital-unexo-and-all-shareholders-on-the-sale-of-the-bharal-group-to-naxicap-partners/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, 20 october 2026 – Jeantet advised FrenchFood Capital, Unexo and all shareholders of Bharal Développement, the parent company of Difagri, Alinova and the Dietagro Group, on the sale of the Group to Naxicap Partners. Naxicap Partners becomes the majority shareholder alongside the management team led by Cédric de Boulogne and new minority investors Sodero and BNP Développement.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;Founded in 1973 and headquartered in Montaigu, Vendée, the Group is one of France’s leading players in the formulation and manufacture of specialised nutritional and dietary products for livestock. It markets more than 4,000 products under its own brands or private-label arrangements, primarily serving the cattle, sheep, pig and poultry sectors. The Group operates several industrial sites in western France and a subsidiary in Vietnam, has a presence in more than 40 countries and generated revenue of nearly €44 million for the financial year ended April 2026, with approximately 90 employees.&lt;/p&gt;</description></item><item><title>Jeantet advised Smac on its acquisition of a majority stake in Les Étancheurs Parisiens</title><link>https://www.jeantet.fr/en/news/2026-02-27-jeantet-advised-smac-on-its-acquisition-of-a-majority-stake-in-les-etancheurs-parisiens/</link><pubDate>Fri, 27 Feb 2026 17:13:59 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2026-02-27-jeantet-advised-smac-on-its-acquisition-of-a-majority-stake-in-les-etancheurs-parisiens/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, February 18, 2026 – Jeantet advised the Smac Group, a major player in energy-efficient building renovation, on its acquisition of a majority stake in Les Étancheurs Parisiens, a company specializing in waterproofing work for condominium associations.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;Founded in 2013, Les Étancheurs Parisiens is a recognized player in the renovation of roof terraces in Paris. The company, which employs 30 people, generated €7.5 million in revenue in 2025.&lt;br&gt;&#10;This transaction is part of Smac’s external growth strategy. Smac, a leading player in building energy renovation, is owned by Compagnie Financière Jousset and supported by Ceres&lt;br&gt;&#10;Industries Capital, relying on 2,500 employees and 67 locations in France and internationally.&lt;/p&gt;</description></item><item><title>Jeantet advises Smac on the acquisition of Avenir Métal and SN Alt’O</title><link>https://www.jeantet.fr/en/news/2025-12-16-jeantet-advises-smac-on-the-acquisition-of-avenir-metal-and-sn-alto/</link><pubDate>Tue, 16 Dec 2025 12:41:41 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2025-12-16-jeantet-advises-smac-on-the-acquisition-of-avenir-metal-and-sn-alto/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, December 12, 2025 – Jeantet advised the Smac group on the acquisition of the entire share capital of Avenir Métal and SN Alt’O, two companies specializing in roof renovation and maintenance, with combined revenues of approximately €15 million.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;This external growth operation is part of the build-up strategy pursued by Smac since Compagnie Financière Jousset acquired a stake in the company, with the aim of achieving €1 billion in revenue by 2030. Following an initial acquisition in the summer of 2025, Smac is now completing two new operations aimed at strengthening its regional presence.&lt;/p&gt;</description></item><item><title>Jeantet advises Pegase Healthcare in connection with its acquisition of the Com&amp;Co Group</title><link>https://www.jeantet.fr/en/news/2024-05-31-jeantet-advises-pegase-healthcare-in-connection-with-its-acquisition-of-the-comco-group/</link><pubDate>Fri, 31 May 2024 14:44:41 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2024-05-31-jeantet-advises-pegase-healthcare-in-connection-with-its-acquisition-of-the-comco-group/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, May 31, 2024 – Jeantet advised Pegase Healthcare, a strategy and communications consultancy firm that supports transformations in the healthcare sector, in LBO with Turenne Santé since 2022, on the acquisition of Com&amp;amp;Co, a Marseille-based player in medical training and conference organizer with sales of almost €10 million.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;This external growth will enable the oncology strategy consulting group headed by Dimitri Verza to complement its therapeutic expertise and sectors.&lt;/p&gt;</description></item><item><title>Jeantet advises Turenne in connection with an owner by out (OBO) in the capital of Vitalis</title><link>https://www.jeantet.fr/en/news/2023-05-22-jeantet-advises-turenne-in-connection-with-an-owner-by-out-obo-in-the-capital-of-vitalis/</link><pubDate>Mon, 22 May 2023 11:03:42 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2023-05-22-jeantet-advises-turenne-in-connection-with-an-owner-by-out-obo-in-the-capital-of-vitalis/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, May 17, 2023, Jeantet has advised Turenne, an independent private equity firm, on an &lt;em&gt;owner by out&lt;/em&gt; (OBO) in the capital of Vitalis, the family-owned group based in the north of France and the number one independent packer and trader of potatoes and fresh seasonings.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;&lt;strong&gt;The family-owned Vitalis Group,&lt;/strong&gt; with revenues estimated at €150 million in 2022, is opening up its capital for the first time to a consortium of funds managed by Turenne and Crédit Agricole,&lt;br&gt;&#10;injecting some €20 million in equity, CBs and revival bonds. The capital restructuring brings in minority shareholders from Crédit Agricole’s two regional subsidiaries, Nord Capital Investissement and Sofipaca, as well as the Regain340 and Obligations Relance funds managed by Turenne Groupe.&lt;/p&gt;</description></item><item><title>Jeantet advises the Gifi group on its acquisition of a minority stake in the share capital of Bricolex</title><link>https://www.jeantet.fr/en/news/2023-04-20-jeantet-advises-the-gifi-group-on-its-acquisition-of-a-minority-stake-in-the-share-capital-of-bricolex/</link><pubDate>Thu, 20 Apr 2023 09:57:56 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2023-04-20-jeantet-advises-the-gifi-group-on-its-acquisition-of-a-minority-stake-in-the-share-capital-of-bricolex/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, April 20, 2023 – Jeantet advised the Gifi group, specialized in the retail distribution of home decoration and bazaar products under the “GIFI” brand, on its acquisition of a minority stake, through its subsidiary Gifi Mag, in Le Chamois, specialized in the retail sale of do-it-yourself products under the “Bricolex” brand.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;The Gifi group, controlled by Groupe Philippe Ginestet, is specialized in the retail distribution of home decoration and bazaar products, and operates a network of 600 stores under the “GIFI” brand, including around 40 abroad.&lt;/p&gt;</description></item><item><title>Jeantet advises the Sulo Group in connection with the acquisition of Delphi Environnement</title><link>https://www.jeantet.fr/en/news/2023-02-01-jeantet-advises-the-sulo-group-in-connection-with-the-acquisition-of-delphi-environnement/</link><pubDate>Wed, 01 Feb 2023 11:54:55 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2023-02-01-jeantet-advises-the-sulo-group-in-connection-with-the-acquisition-of-delphi-environnement/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, January 31, 2023, Jeantet has advised the Sulo Group, a specialist in waste management solutions, in connection with its acquisition of Delphi Environnement, a company specializing in the maintenance of cardboard presses.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;The &lt;strong&gt;SULO Group&lt;/strong&gt; acquires &lt;strong&gt;Delphi Environnement SAS&lt;/strong&gt;, a French company based in Bonlier in the Oise region since 2005 and specialized in the maintenance of cardboard presses and other recyclable waste.&lt;/p&gt;&#10;&lt;p&gt;This acquisition will provide proximity and responsiveness to their clients with service and maintenance activities. More than 25 new employees will join SULO and the service activity.&lt;/p&gt;</description></item><item><title>Jeantet advises Dzeta in connection with its acquisition of a participating interest in Akesa</title><link>https://www.jeantet.fr/en/news/2023-01-28-jeantet-advises-dzeta-in-connection-with-its-acquisition-of-a-participating-interest-in-akesa/</link><pubDate>Sat, 28 Jan 2023 11:15:27 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2023-01-28-jeantet-advises-dzeta-in-connection-with-its-acquisition-of-a-participating-interest-in-akesa/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, January 27, 2023, Jeantet advised Dzeta, Claude Darmon’s family office, in connection with its acquisition of a participating interest in Akesa, a company specializing in cleaning services, via a capital increase.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;Dzeta Conseil enters the capital of Akesa and engages in a new sector, the cleaning industry, via a minority investment. This capital increase aims to follow a buy and build strategy to double in size&lt;br&gt;&#10;by 2025 with the support of Dzeta, alongside the two founders of Akesa, Mélanie and Frédéric Maraillet.&lt;/p&gt;</description></item><item><title>Jeantet advises Webedia in connection with the sale of Semantiweb to the European Digital Group</title><link>https://www.jeantet.fr/en/news/2023-01-27-jeantet-advises-webedia-in-connection-with-the-sale-of-semantiweb-to-the/</link><pubDate>Fri, 27 Jan 2023 11:21:53 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2023-01-27-jeantet-advises-webedia-in-connection-with-the-sale-of-semantiweb-to-the/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, January 27, 2023, Jeantet has advised Webedia, a French online media group, on the sale of Semantiweb, an agency specialized in conversational data analysis, to European Digital Group, a digital transformation specialist.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;European Digital Group (EDG) is accelerating its external growth and strengthening its data business through the acquisition of Semantiweb, an agency specializing in the analysis of consumer conversations on social networks.&lt;/p&gt;&#10;&lt;p&gt;This acquisition aims to strengthen the company’s social networks, brand content and SEO branch as well as its expertise in “social media listening”.&lt;/p&gt;</description></item><item><title>Jeantet appoints four new partners</title><link>https://www.jeantet.fr/en/news/2023-01-06-jeantet-coopte-quatre-nouveaux-associes/</link><pubDate>Fri, 06 Jan 2023 11:39:30 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2023-01-06-jeantet-coopte-quatre-nouveaux-associes/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, 1st January 2023 – Jeantet announces the appointment of 4 new partners on 1st January 2023: Maxime Brotz (M&amp;amp;A), Guillaume Fornier (M&amp;amp;A), Adrien Fourmon (Public Law), Olivier Lyon Lynch (Banking-Finance-Insurance).&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;As part of its development and growth strategy, Jeantet announces, barely one month after the arrival of 3 new lateral partners, the appointment of 4 new partners. The firm thus confirms its confidence in and support for the many talents that make up its teams and demonstrates its desire to strengthen its expertise in strategic areas in order to enhance its position as a leading multidisciplinary firm in the market.&lt;/p&gt;</description></item><item><title>Jeantet advises Port Designs in connection with its acquisition of a majority interest in Noatic</title><link>https://www.jeantet.fr/en/news/2022-12-22-jeantet-conseille-port-designs-dans-le-cadre-de-sa-prise-de-participation-majoritaire-au-sein-de-naotic/</link><pubDate>Thu, 22 Dec 2022 16:17:28 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2022-12-22-jeantet-conseille-port-designs-dans-le-cadre-de-sa-prise-de-participation-majoritaire-au-sein-de-naotic/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, le 22 décembre 2022 – Jeantet advised the Port Designs Group, a company specialized in IT mobility, owned by the investment company Dzeta Conseil, in connection with its acquisition of a majority interest in Naotic.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;&lt;strong&gt;Port Designs&lt;/strong&gt;, under the control of Dzeta Conseil for the past year, specializes in the distribution of luggage for the transportation of computers and tablets and computer accessories. It is celebrating this anniversary by entering into a first build-up through the acquisition of 100% of Naotic’s shares.&lt;/p&gt;</description></item><item><title>Jeantet advises Turenne Santé in its acquisition of a minority stake in the capital of the Kephren Group</title><link>https://www.jeantet.fr/en/news/2022-12-16-jeantet-conseille-turenne-sante-dans-le-cadre-de-sa-prise-de-participation-minoritaire-au-capital-de-groupe-kephren/</link><pubDate>Fri, 16 Dec 2022 17:25:40 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2022-12-16-jeantet-conseille-turenne-sante-dans-le-cadre-de-sa-prise-de-participation-minoritaire-au-capital-de-groupe-kephren/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, December 16, 2022, Jeantet advised Turenne Santé in its acquisition of a minority stake in the capital of Kephren, Kephren Publishing, Cassiopea Production &amp;amp; Broadcasting, Geriamed and Olimpe, companies dedicated to strategy consulting and communication in the healthcare sector.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;The group welcomes &lt;strong&gt;Turenne Santé&lt;/strong&gt; via its FPCI Capital Santé 2 as a minority shareholder, through the creation of an investment vehicle alongside the founder and manager, Dimitri Verza, and the management team. Turenne Santé is joining the group to provide it with the financial resources and support it needs to implement an ambitious development plan through both external and organic growth.&lt;/p&gt;</description></item><item><title>Jeantet advises the China Medical System Group in connection with the acquisition of a participating interest in Eye Tech Care</title><link>https://www.jeantet.fr/en/news/2022-09-15-jeantet-advises-the-china-medical-system-group-in-connection-with-the-acquisition-of-a-participating-interst-in-eye-tech-care/</link><pubDate>Thu, 15 Sep 2022 19:28:27 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2022-09-15-jeantet-advises-the-china-medical-system-group-in-connection-with-the-acquisition-of-a-participating-interst-in-eye-tech-care/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, 15 September 2022 – Jeantet has advised the Chinese group China Medical System in the context of (i) the acquisition of a participating interest, through certain subsidiaries of the group, of around 33.4% of the share capital of the French company Eye Tech Care and (ii) the signature of a license, collaboration and distribution agreement relating to the ultrasound glaucoma treatment device EyeOP1®.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;Based in Shenzhen, the &lt;strong&gt;China Medical System group&lt;/strong&gt; is a leader in the development and distribution of new medical treatments, particularly in the fields of dermatology and ophthalmology. This transaction aims to provide a new high-quality treatment option for glaucoma patients in China and Southeast Asian countries.&lt;/p&gt;</description></item><item><title>Jeantet advises Turenne Santé in connection with its acquisition of a minority stake in Phodé</title><link>https://www.jeantet.fr/en/news/2022-02-15-jeantet-conseille-turenne-sante-dans-le-cadre-de-son-entree-minoritaire-au-capital-de-phobe/</link><pubDate>Tue, 15 Feb 2022 17:06:54 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2022-02-15-jeantet-conseille-turenne-sante-dans-le-cadre-de-son-entree-minoritaire-au-capital-de-phobe/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, February 15, 2022 – Jeantet advised Turenne Santé in connection with its acquisition of a minority stake in Phodé.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;This transaction allowed the exit of historical shareholders (including the investment fund Oraxys Environment 1) and the entry into the capital of the management team led by Damien Guillobez, who will become part of the group’s operational management.&lt;/p&gt;&#10;&lt;p&gt;With over €280 million under management, including more than €185 million for the FPCI Capital Santé 2, Turenne Santé supports healthcare companies in their development and transfer challenges. Turenne Groupe, one of France’s leading private equity firms, has been helping entrepreneurs with their innovation, development and transfer projects for more than 20 years.&lt;/p&gt;</description></item><item><title>Jeantet advises Turenne Santé in connection with its acquisition of a minority stake in H.A.C.Pharma to support the company’s development and strengthen its product portfolio</title><link>https://www.jeantet.fr/en/news/2022-02-02-jeantet-conseille-turenne-sante-dans-le-cadre-de-son-entree-minoritaire-au-capital-dh-a-c-pharma-pour-accompagner-la-societe-dans-son-developpement-et-renforcer-son-portefeuille-de-produits/</link><pubDate>Wed, 02 Feb 2022 12:11:54 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2022-02-02-jeantet-conseille-turenne-sante-dans-le-cadre-de-son-entree-minoritaire-au-capital-dh-a-c-pharma-pour-accompagner-la-societe-dans-son-developpement-et-renforcer-son-portefeuille-de-produits/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, February 2, 2022– Jeantet advised Turenne Santé in connection with its acquisition of a minority stake in the pharmaceutical company H.A.C. Pharma, via the FPCI (&lt;em&gt;Fonds Professionnel de Capital Investissement&lt;/em&gt;, or Professional private equity investment fund) Capital Santé 2, as lead investor, and BNP Paribas Développement. This transaction marks a new stage in the company’s development, as it seeks to continue launching new drugs and accelerate the expansion of its product portfolio.&lt;/strong&gt;&lt;/p&gt;</description></item><item><title>Jeantet advises Dzeta in connection with its acquisitions of majority interests in Technigrès and PORT Designs</title><link>https://www.jeantet.fr/en/news/2022-01-14-jeantet-conseille-dzeta-dans-le-cadre-de-ses-prises-de-participations-majoritaires-au-sein-de-technigres-et-port-designs/</link><pubDate>Fri, 14 Jan 2022 17:07:03 +0000</pubDate><guid>https://www.jeantet.fr/en/news/2022-01-14-jeantet-conseille-dzeta-dans-le-cadre-de-ses-prises-de-participations-majoritaires-au-sein-de-technigres-et-port-designs/</guid><description>&lt;p&gt;&lt;strong&gt;Paris, January 11, 2022 – Jeantet advised the investment company Dzeta in connection with its acquisitions of majority interests in Technigrès and PORT Designs. Through these two deals, Dzeta confirms its investment diversification policy.&lt;/strong&gt;&lt;/p&gt;&#10;&lt;p&gt;&lt;strong&gt;Dzeta&lt;/strong&gt;, which was established in 2009, assists companies in their development strategy and in improving their operational and financial performance through investments in many sectors such as business services, B2B or B2C distribution, industry, TMT, ready-to-wear, etc.&lt;/p&gt;</description></item></channel></rss>